DJIA 17,172.68 -107.06 -0.62%
NASDAQ 4,527.69 -52.10 -1.14%
S&P 500 1,994.29 -16.11 -0.80%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

40.71 -1.57 (-3.71%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $40.71 -3.71%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $42.04
Previous Close $42.28
Daily Range $39.68 - $42.21
52-Week Range $22.25 - $62.66
Market Cap $4.8B
P/E Ratio -52.20
Dividend (Yield) $0.00 (0.0%)
Volume 1,923,345
Average Daily Volume 2,178,449
Current FY EPS -$0.70





Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary Rss Feed

3 Biotechs Investors Should Watch

The healthcare version of Where the Money Is.

Isis Pharmaceuticals Up on $4M Milestone Payment - Analyst Blog

Isis Pharmaceuticals Up on $4M Milestone Payment - Analyst Blog

Jim Cramer's Top Stock Picks: ISIS DDD CY

Isis Pharmaceuticals Earns $4M from Achaogen For The Initiation Of A Phase 3 Study Of Plazomicin

Why Anxious Investors' Pressure Could Push Small Cap Stocks Lower

Isis Pharmaceuticals (ISIS) Weak On High Volume Today

Why ISIS Pharmaceuticals Inc. Stock Is Flat in 2014

ISIS Pharmaceuticals shares have rebounded since spring, but still remain unchanged this year as investors digest a big stock move last year and wait for further proof that antisense RNA technology has blockbuster potential.

Jim Cramer's Top Stock Picks: TWTR TASR ACAD ISIS RH

Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's Post-Market Leader Stock

October 31st Options Now Available For Isis Pharmaceuticals (ISIS)

See More ISIS News...

ISIS's Top Competitors

ISIS $40.71 (-3.71%)
Current stock: ISIS
AMGN $142.18 (-1.27%)
Current stock: AMGN
GILD $105.47 (-0.46%)
Current stock: GILD
BIIB $329.76 (0.16%)
Current stock: BIIB